Upcoming Health Conferences in Boston, United States

With recent advancements into Phase II and III trials for personalized cancer vaccines along with 437 other candidates in development, the biopharm...

Join 80+ CapEx, Construction and Engineering professionals from leading pharma, biotech, CDMO and medtech companies across to the United Stated to ...

As supply issues with Ozempic persist for Novo Nordisk, and Eli Lilly launch an unconventional but affordable single-dose version of Zepbound; ther...

Achieving Efficacy and Exploring Indication Expansion for Complement Inhibitors The complement community is shifting gear, with more companies t...

With recent accelerated approval wins, positive clinical trial readouts, progression through clinical pipelines and exciting mergers and acquisitio...

With Remix Therapeutics joining forces with Roche and Daiichi Sankyo partnering with Depixus, there has been many valuable collaborations entering ...

In the face of unprecedented cost-per-patient expenses, the FDA's recent focus on rare disease, and a myriad of options for identifying, engaging, ...

Uniting Large Pharma, Innovative Biotech and Leading Academics to Eliminate the Boundaries of Druggability with Novel Covalent Drugs With contin...

As innovative drug delivery platforms beyond GalNac continue to emerge and novel chemical modifications are discovered, the potential for RNAi ther...

Making Strides in Targeting PARP, ATR, ATM, WEE1 and POLθ AstraZeneca and Merck are at the forefront of DDR inhibitor development, focusing on ...

Propel Kinase Biology Understanding to Increase Selectivity, Overcome Resistance and Find the Optimal Combination Partner to Develop Best and First...

Accelerate collaboration and partnering across neurology and psychiatry pipelines and technologies, to reduce risk, validate technologies, and deli...